<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Endoscopic variceal ligation
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Endoscopic variceal ligation
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Endoscopic variceal ligation
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            John S Goff, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            John R Saltzman, MD, FACP, FACG, FASGE, AGAF
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Kristen M Robson, MD, MBA, FACG
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jan 23, 2024.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patients with cirrhosis who develop portal hypertension (ie, increased pressure within the portal venous system) are at risk for complications, including bleeding from esophageal varices. Endoscopic variceal ligation (EVL) was developed in an effort to find an effective endoscopic treatment for esophageal varices with fewer complications than endoscopic sclerotherapy (ie, endoscopic injection of a sclerosant solution into the varices) [
         <a href="#rid1">
          1,2
         </a>
         ]. The EVL technique is similar to hemorrhoidal banding; it works by capturing the varix within a small band, resulting in occlusion from thrombosis. The tissue then becomes necrotic and sloughs off in a few days to weeks, leaving a superficial mucosal ulceration that will heal completely. EVL avoids the use of sclerosant solution and thus eliminates the risk of transmural injury to the esophageal wall that often occurs after endoscopic sclerotherapy.
        </p>
        <p>
         The use of EVL for treating esophageal varices was first reported in 1988 [
         <a href="#rid3">
          3
         </a>
         ]. Since then, advances in the technique have led to its routine use for treating patients with esophageal varices. One major advance was the development of the multiple-band ligating device, which has simplified and improved the safety of EVL.
        </p>
        <p>
         This topic will review the clinical applications, procedure technique, and complications of EVL.
        </p>
        <p>
         The American Association for the Study of Liver Diseases has published guidance for the management of patients with portal hypertension and variceal bleeding, and our approach is generally consistent with society guidance [
         <a href="#rid4">
          4
         </a>
         ]. Consensus statements have also been published by the British Society of Gastroenterology and by Baveno VII Consensus Workshop [
         <a href="#rid5">
          5,6
         </a>
         ].
        </p>
        <p>
         Additional methods for achieving hemostasis in patients with acute variceal bleeding are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/1260.html" rel="external">
          "Methods to achieve hemostasis in patients with acute variceal hemorrhage"
         </a>
         .)
        </p>
        <p>
         The complications and general management of cirrhosis are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/1263.html" rel="external">
          "Cirrhosis in adults: Overview of complications, general management, and prognosis"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2617012016">
         <span class="h1">
          CLINICAL APPLICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Clinical applications for EVL include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Bleeding prevention:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         EVL is used for primary bleeding prevention for selected patients (ie, those with medium to large esophageal varices who cannot tolerate nonselective beta blocker therapy). (See
         <a class="medical medical_review" href="/z/d/html/1245.html" rel="external">
          "Primary prevention of bleeding from esophageal varices in patients with cirrhosis"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1244.html" rel="external">
          "Pathogenesis of variceal bleeding in patients with cirrhosis", section on 'Size of varices'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         EVL is performed to eradicate varices and to prevent rebleeding in patients who have recovered from an episode of esophageal variceal bleeding. (See
         <a class="medical medical_review" href="/z/d/html/1252.html" rel="external">
          "Prevention of recurrent bleeding from esophageal varices in patients with cirrhosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Management of acute bleeding from esophageal varices. (See
         <a class="medical medical_review" href="/z/d/html/1254.html" rel="external">
          "Overview of the management of patients with variceal bleeding"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/1260.html" rel="external">
          "Methods to achieve hemostasis in patients with acute variceal hemorrhage"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H810597835">
         <span class="h1">
          CONTRAINDICATIONS
         </span>
         <span class="headingEndMark">
          —
         </span>
         In general, the following is regarded as a contraindication to EVL:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Type of varices – We do not typically use EVL for treating large gastroesophageal varices along the lesser curvature of the stomach (GOV1) or gastroesophageal varices extending into the fundus (GOV2) (ie, size assessment by endoscopic ultrasound). In addition, we do not use EVL to treat isolated gastric varices located in the fundus (IGV1), regardless of size. Management of bleeding gastric varices is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/1260.html" rel="external">
          "Methods to achieve hemostasis in patients with acute variceal hemorrhage", section on 'Management of gastric varices'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         Contraindications to upper gastrointestinal endoscopy (required to perform EVL) are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/13928.html" rel="external">
          "Overview of upper gastrointestinal endoscopy (esophagogastroduodenoscopy)", section on 'Contraindications'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          PROCEDURE FOR LIGATING VARICES
         </span>
        </p>
        <p class="headingAnchor" id="H3125486878">
         <span class="h2">
          Nonurgent procedures (prophylaxis)
         </span>
        </p>
        <p class="headingAnchor" id="H1378438470">
         <span class="h3">
          Preprocedure preparation
         </span>
         <span class="headingEndMark">
          —
         </span>
         Patient preparation for upper endoscopy with endoscopic variceal ligation (ie, dietary restrictions, medication use) is similar to preparation for diagnostic upper endoscopy with the following additions (see
         <a class="medical medical_review" href="/z/d/html/13928.html" rel="external">
          "Overview of upper gastrointestinal endoscopy (esophagogastroduodenoscopy)", section on 'Patient preparation'
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Preprocedure testing – We typically do not obtain laboratory studies prior to a nonurgent procedure if a complete blood count and INR have been checked within the previous three months:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Based on clinical experience, patients with platelet count ≥50,000/microL and INR ≤2 are at minimal risk for bleeding related to EVL.
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         The approach to patients with cirrhosis and platelet count &lt;50,000/microL and/or INR &gt;2 is individualized based several factors including procedure timing, severity of thrombocytopenia, and risk factors for coexisting hemostatic disorders (eg, nutritional status, use of vitamin K antagonists) [
         <a href="#rid7">
          7
         </a>
         ], and these issues are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/13932.html" rel="external">
          "Hemostatic abnormalities in patients with liver disease", section on 'General approach to invasive procedures'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sedation assessment – Most patients who are undergoing nonurgent endoscopy with EVL receive monitored anesthesia care, while the approach to procedural sedation depends on several factors (eg, medication history, comorbidities, history of difficult airway). These issues are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/105511.html" rel="external">
          "Anesthesia for gastrointestinal endoscopy in adults"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Antibiotics – For patients who are not actively bleeding, antibiotic prophylaxis is not required prior to EVL. While transient bacteremia has been documented after EVL, it is not regarded as a high-risk procedure for infection [
         <a href="#rid8">
          8
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1155111230">
         <span class="h3">
          Equipment
         </span>
         <span class="headingEndMark">
          —
         </span>
         Ligating devices are used to place the band on a varix after it has been suctioned into a clear plastic cylinder attached to the tip of the endoscope [
         <a href="#rid9">
          9
         </a>
         ]. Multiple ligator devices typically contain between 4 and 10 bands that can be deployed in immediate succession. Ligating devices with multiple, preloaded bands have largely replaced single ligator systems. Prior to the availability of multiple ligators, overtube placement was generally required because the endoscope had to be removed to load each band individually, and then the endoscope was reinserted into the esophagus [
         <a href="#rid10">
          10
         </a>
         ]. Use of a multiple ligator device avoids potential overtube-related complications and is also associated with shorter procedure times [
         <a href="#rid11">
          11-13
         </a>
         ].
        </p>
        <p>
         Commercially available ligating devices include [
         <a href="#rid14">
          14
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Boston-Scientific – SpeedBand SuperView Super 7
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Wilson-Cook – 4, 6, and 10 Shooter Saeed Multi-Band Ligators
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3888042675">
         <span class="h3">
          Technique
         </span>
        </p>
        <p class="headingAnchor" id="H365871314">
         <span class="h4">
          Performing diagnostic endoscopy
         </span>
         <span class="headingEndMark">
          —
         </span>
         Diagnostic upper endoscopy is performed prior to banding to examine the upper gastrointestinal tract and to identify esophageal varices that require treatment:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients without bleeding – For patients undergoing EVL for bleeding prevention, the goal is to eradicate all varices, while medium and large varices are the primary targets  (
         <a class="graphic graphic_picture graphicRef61770" href="/z/d/graphic/61770.html" rel="external">
          picture 1
         </a>
         ). Assessment of varix size is done with the esophagus insufflated to avoid overestimating the size. (See
         <a class="medical medical_review" href="/z/d/html/1244.html" rel="external">
          "Pathogenesis of variceal bleeding in patients with cirrhosis", section on 'Size of varices'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients with active or recent bleeding – Actively bleeding varices or those with stigmata indicating recent bleeding (such as red wale marks or cherry red spots) are selected as primary targets for banding even if they are not located at the gastroesophageal junction  (
         <a class="graphic graphic_picture graphicRef50222" href="/z/d/graphic/50222.html" rel="external">
          picture 2
         </a>
         ). Factors that predict a higher risk of bleeding (eg, varix appearance, size) are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/1244.html" rel="external">
          "Pathogenesis of variceal bleeding in patients with cirrhosis", section on 'Predictive factors'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         We measure the distance from the mouth to the most distal targeted varix and to the gastroesophageal junction, since visibility may be reduced once the banding device is placed over the tip of the endoscope. For example, the site of the most distal varix and the gastroesophageal junction may be located at approximately 40 cm from the mouth. These measurements help provide landmarks; in addition, some ligating devices have transparent caps, which have improved endoscopic visualization [
         <a href="#rid10">
          10
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3640213589">
         <span class="h4">
          Loading banding device onto endoscope
         </span>
         <span class="headingEndMark">
          —
         </span>
         Following the diagnostic upper endoscopy, the endoscope is removed from the patient, and the ligating device with preloaded bands is placed onto the endoscope. The device typically has a soft sheath portion that fits over the tip of the endoscope and a hard plastic portion (or chamber) that extends beyond the tip. Bands are stretched over the hard portion at the distal end of the device and later deployed onto the varices. (See
         <a class="local">
          'Deploying bands'
         </a>
         below.)
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h4">
          Deploying bands
         </span>
         <span class="headingEndMark">
          —
         </span>
         Band deployment is accomplished by identifying a varix, suctioning the varix and its surrounding mucosa into the chamber (or cap) at the endoscope's tip, tightening the trip wire to deploy the band onto the varix, and lastly, releasing suction:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         After the endoscope and the ligating device have been reinserted into the esophagus, the first targeted varix is identified. We begin by treating the most distal varices (typically located at or just proximal to the gastroesophageal junction), and then ascend proximally in the esophagus (for approximately 5 to 8 cm), since deployed bands partially occlude the esophageal lumen.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         After a target varix is identified, the endoscope is pointed toward it and then suction is applied to the mucosa to fill the chamber at the tip of the endoscope. If an adequate amount of tissue has been captured by the device, there will be a "red-out" appearance (caused by close approximation of the mucosa overlying the varix to the lens on the tip of the endoscope). Trying to place a band on a small amount of overlying mucosa will usually result in the band not adhering to the mucosa (or initially adhering and subsequently sliding off); this may also cause superficial mucosal damage with subsequent bleeding.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The band is deployed by tightening the trip wire, and this is done by turning the dial located at the top of the endoscope's working channel.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Following band deployment, suction is released.
        </p>
        <p>
        </p>
        <p>
         The process is then repeated. Bands are usually applied in a circumferential pattern, spiraling gradually up the esophagus until all columns of medium to large varices have undergone placement of one to three bands  (
         <a class="graphic graphic_picture graphicRef54194" href="/z/d/graphic/54194.html" rel="external">
          picture 3
         </a>
         ).
        </p>
        <p>
         Additional tips for band deployment include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         As bands are applied to the mucosa, less tissue is available to suction into the chamber. This indicates that another site (eg, more proximal site) needs to be selected for the next band deployment.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         After a varix is banded, the endoscope is not typically advanced distally (ie, beyond the site) to avoid dislodging the band [
         <a href="#rid9">
          9
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         On occasion, esophageal mucosa without an underlying varix may be unintentionally banded; this is not associated with any immediate adverse effects [
         <a href="#rid9">
          9
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Reduced visibility due to blood accumulating within the device chamber (or due to the ligating device itself) can make EVL challenging [
         <a href="#rid15">
          15
         </a>
         ]. If visualization is limited due to active bleeding, bands can be placed at the gastroesophageal junction without identifying a specific varix. This approach may result in less bleeding, and directed band placement can be accomplished once the field of vision improves. In addition, the accumulation of blood can often be overcome by injecting water through a blunt needle passed along the device wire as it exits from the channel located on the endoscope handle.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Patients who are returning for a subsequent banding session may have esophageal mucosal ulceration from prior banding. A band can be safely placed near or adjacent to band-induced ulceration. However, we avoid suctioning the ulcerated mucosa whenever possible to avoid inducing ulcer bleeding.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H277840468">
         <span class="h4">
          Determining number of bands per session
         </span>
         <span class="headingEndMark">
          —
         </span>
         The goal of EVL is to eradicate varices in the lower 5 to 8 cm of the esophagus. There is theoretically no maximum number of bands that can be applied per session. However, for patients without active bleeding, ≤6 bands are typically placed during each endoscopic session [
         <a href="#rid16">
          16
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h3">
          Postprocedure care
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Diet – Following nonurgent EVL, we advise patients to adhere to a liquid diet for 12 hours and then progress to soft foods as tolerated.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Symptom management – Symptoms such as retrosternal pain or dysphagia immediately after banding are uncommon. However, some patients may develop symptoms that typically resolve within one to two days. Transient symptoms may be treated with an oral solution consisting of a topical anesthetic (topical
         <a class="drug drug_general" data-topicid="9558" href="/z/d/drug information/9558.html" rel="external">
          lidocaine
         </a>
         ) combined with an antacid (eg, magnesium
         <a class="drug drug_general" data-topicid="8499" href="/z/d/drug information/8499.html" rel="external">
          aluminum hydroxide
         </a>
         ), which is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/1152.html" rel="external">
          "Oral toxicity associated with systemic anticancer therapy", section on 'Analgesia'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2750229550">
         <span class="h2">
          Urgent procedures (active bleeding)
         </span>
         <span class="headingEndMark">
          —
         </span>
         The approach to variceal ligation for patients with active bleeding is generally similar to the care of patients who are undergoing prophylactic banding, with the following exceptions (see
         <a class="local">
          'Nonurgent procedures (prophylaxis)'
         </a>
         above):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Antibiotic prophylaxis – For patients with cirrhosis and active variceal bleeding, prophylactic antibiotics are given to lower the risk of infection, and this is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/1254.html" rel="external">
          "Overview of the management of patients with variceal bleeding", section on 'Antibiotic prophylaxis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Airway protection – Patients with hematemesis from variceal bleeding are typically intubated for airway protection, and this also facilitates performing upper endoscopy. (See
         <a class="medical medical_review" href="/z/d/html/1254.html" rel="external">
          "Overview of the management of patients with variceal bleeding", section on 'Resuscitation and support'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Preprocedure testing – Complete blood count and coagulation studies are obtained prior to the procedure. The approach to addressing hemostatic abnormalities in patients with cirrhosis and active bleeding is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/13932.html" rel="external">
          "Hemostatic abnormalities in patients with liver disease", section on 'Bleeding'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Number of bands – Four to six bands are typically used for achieving initial hemostasis. In a randomized trial including 86 patients with varices, compared with placing ≤6 bands, placement of &gt;6 bands per session was not more beneficial but did result in longer procedures and increased number of misfired bands [
         <a href="#rid16">
          16
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Postprocedure care:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Nutrition – Nutritional support and timing of restarting oral intake for patients with variceal bleeding is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/1254.html" rel="external">
          "Overview of the management of patients with variceal bleeding", section on 'Nutritional support'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Nasogastric tube – We avoid placing a nasogastric tube after EVL to avoid inadvertently dislodging the newly placed bands, while data to support this practice are limited [
         <a href="#rid17">
          17
         </a>
         ]. However, if a nasogastric tube is needed (eg, gastric decompression, enteral administration of medications), a tube may be gently passed by an experienced clinician following band placement.
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H3498827478">
         <span class="h1">
          PATIENT FOLLOW-UP
         </span>
         <span class="headingEndMark">
          —
         </span>
         Most patients require more than one session of EVL to eradicate varices, and after eradication, surveillance endoscopy is performed [
         <a href="#rid4">
          4
         </a>
         ]:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Primary prevention – Patients undergoing EVL for primary prophylaxis undergo upper endoscopy with EVL approximately every two to four weeks until varices are eradicated. (See
         <a class="medical medical_review" href="/z/d/html/1245.html" rel="external">
          "Primary prevention of bleeding from esophageal varices in patients with cirrhosis", section on 'Preventive strategies'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Secondary prevention – Patients with a history of esophageal variceal bleeding undergo upper endoscopy with EVL every two to four weeks until the varices are eradicated. (See
         <a class="medical medical_review" href="/z/d/html/1252.html" rel="external">
          "Prevention of recurrent bleeding from esophageal varices in patients with cirrhosis", section on 'Endoscopic variceal ligation alone'
         </a>
         .)
        </p>
        <p>
        </p>
        <p>
         After eradication of esophageal varices, the first surveillance upper endoscopy is performed three to six months after variceal eradication and then every 12 months to check for recurrence.
        </p>
        <p class="headingAnchor" id="H8">
         <span class="h1">
          EFFICACY
         </span>
        </p>
        <p class="headingAnchor" id="H10">
         <span class="h2">
          Prevention of bleeding
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Efficacy of EVL for preventing rebleeding in patients who have recovered from esophageal variceal bleeding is presented separately. (See
         <a class="medical medical_review" href="/z/d/html/1252.html" rel="external">
          "Prevention of recurrent bleeding from esophageal varices in patients with cirrhosis", section on 'Options'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Efficacy of EVL for primary prevention of variceal bleeding in selected patients (ie, those with medium to large varices who cannot tolerate beta blocker prophylaxis) is also presented separately. (See
         <a class="medical medical_review" href="/z/d/html/1245.html" rel="external">
          "Primary prevention of bleeding from esophageal varices in patients with cirrhosis", section on 'Endoscopic variceal ligation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2582161295">
         <span class="h2">
          Control of active bleeding
         </span>
         <span class="headingEndMark">
          —
         </span>
         Efficacy of EVL for controlling active bleeding from esophageal varices is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/1260.html" rel="external">
          "Methods to achieve hemostasis in patients with acute variceal hemorrhage", section on 'Endoscopic variceal ligation and endoscopic sclerotherapy'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h1">
          COMPLICATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H20">
         <span class="h2">
          Band-induced ulcer bleeding
         </span>
         <span class="headingEndMark">
          —
         </span>
         Esophageal ulcers often develop at each ligation site as the banded tissue becomes necrotic and sloughs off, which typically occurs within 3 to 10 days after EVL. However, bleeding from band-induced ulcers is uncommon. Studies have suggested that rates of post-banding ulcer bleeding were approximately 5 percent [
         <a href="#rid18">
          18,19
         </a>
         ]. Risk factors for bleeding from banding-related ulcers included hepatocellular cancer, higher MELD score, and lower beta-blocker doses [
         <a href="#rid19">
          19
         </a>
         ].
        </p>
        <p>
         The post-banding ulcers are superficial and are approximately ≤1 cm in diameter, and most ulcers heal within two to three weeks [
         <a href="#rid20">
          20,21
         </a>
         ]. Prophylaxis with proton pump inhibitor may decrease the ulcer size, while its effect on bleeding risk is uncertain. (See
         <a class="local">
          'Postprocedure care'
         </a>
         above.)
        </p>
        <p class="headingAnchor" id="H21">
         <span class="h2">
          Portal hypertensive gastropathy
         </span>
         <span class="headingEndMark">
          —
         </span>
         A concern with EVL is that it may contribute to or worsen portal hypertensive gastropathy (PHG), which then may bleed [
         <a href="#rid22">
          22,23
         </a>
         ]. An exacerbation of PHG may be related to increased portal pressures and gastric blood flow or to increased mucosal congestion following eradication of esophageal varices [
         <a href="#rid24">
          24,25
         </a>
         ]. However, data supporting this potential effect of EVL are mixed [
         <a href="#rid26">
          26-29
         </a>
         ]. For example, in a study of 22 patients who had EVL, there was no significant difference in hepatic venous pressure gradients when measured before or after eradication of esophageal varices [
         <a href="#rid29">
          29
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H22">
         <span class="h2">
          Other complications
         </span>
         <span class="headingEndMark">
          —
         </span>
         The development of esophageal stricture after banding is uncommon, with a reported incidence of 0 to 2 percent in patients undergoing EVL [
         <a href="#rid30">
          30-32
         </a>
         ].
        </p>
        <p>
         Rarely reported complications include focal esophageal wall necrosis and perforation [
         <a href="#rid33">
          33
         </a>
         ], esophageal obstruction [
         <a href="#rid34">
          34
         </a>
         ], altered esophageal motility [
         <a href="#rid35">
          35
         </a>
         ], paraplegia [
         <a href="#rid36">
          36
         </a>
         ], and decreased oxygen delivery (possibly due to lower cardiac output from a decreased preload) [
         <a href="#rid37">
          37
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/3506.html" rel="external">
          "Pathophysiology of heart failure with reduced ejection fraction: Hemodynamic alterations and remodeling", section on 'Preload'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H812368283">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/114134.html" rel="external">
          "Society guideline links: Gastrointestinal bleeding in adults"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H75704133">
         <span class="h1">
          INFORMATION FOR PATIENTS
         </span>
         <span class="headingEndMark">
          —
         </span>
         UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5
         <sup>
          th
         </sup>
         to 6
         <sup>
          th
         </sup>
         grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10
         <sup>
          th
         </sup>
         to 12
         <sup>
          th
         </sup>
         grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.
        </p>
        <p>
         Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Basics topics (see
         <a class="medical medical_basics" href="/z/d/html/17197.html" rel="external">
          "Patient education: Esophageal varices (The Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beyond the Basics topics (see
         <a class="medical medical_patient" href="/z/d/html/4581.html" rel="external">
          "Patient education: Esophageal varices (Beyond the Basics)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H24">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Background
         </strong>
         – EVL works by capturing an esophageal varix within a small band, resulting in occlusion from thrombosis. The tissue then becomes necrotic and sloughs off in a few days to weeks, leaving a superficial mucosal ulceration that will heal completely. (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         For patients with esophageal varices, EVL is used to treat active bleeding and to prevent future bleeding. (See
         <a class="local">
          'Clinical applications'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Equipment
         </strong>
         – Ligating devices are used to place the band on a varix after it has been suctioned into a clear plastic cylinder attached to the tip of the endoscope. Multiple ligator devices typically contain between 4 and 10 bands that can be deployed in immediate succession; thus an overtube is not needed. (See
         <a class="local">
          'Equipment'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Procedure technique
         </strong>
         – The banding session typically begins with treating the most distal varices (typically located at or just proximal to the gastroesophageal junction), and then ascending proximally in the esophagus, because deployed bands partially occlude the esophageal lumen. Bands are usually applied in a circumferential pattern, spiraling gradually up the esophagus until all columns of medium to large varices have one to three bands  (
         <a class="graphic graphic_picture graphicRef54194" href="/z/d/graphic/54194.html" rel="external">
          picture 3
         </a>
         ). (See
         <a class="local">
          'Deploying bands'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The goal of EVL is to eradicate varices in the lower 5 to 8 cm of the esophagus. There is theoretically no maximum number of bands that can be applied per session. However, for most patients without active bleeding, ≤6 bands are typically placed during each endoscopic session. (See
         <a class="local">
          'Determining number of bands per session'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Efficacy
         </strong>
         – Efficacy data for EVL are discussed separately:
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1245.html" rel="external">
          "Primary prevention of bleeding from esophageal varices in patients with cirrhosis", section on 'Endoscopic variceal ligation'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1260.html" rel="external">
          "Methods to achieve hemostasis in patients with acute variceal hemorrhage", section on 'Endoscopic variceal ligation and endoscopic sclerotherapy'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/1252.html" rel="external">
          "Prevention of recurrent bleeding from esophageal varices in patients with cirrhosis", section on 'Options'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Adverse events
         </strong>
         – Complications related to EVL are uncommon, but they include band-induced ulcer bleeding and esophageal stricture. (See
         <a class="local">
          'Complications'
         </a>
         above.)
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Van Stiegmann G, Cambre T, Sun JH. A new endoscopic elastic band ligating device. Gastrointest Endosc 1986; 32:230.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stiegmann GV, Goff JS, Sun JH, et al. Endoscopic variceal ligation: an alternative to sclerotherapy. Gastrointest Endosc 1989; 35:431.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Van Stiegmann G, Goff JS. Endoscopic esophageal varix ligation: preliminary clinical experience. Gastrointest Endosc 1988; 34:113.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Kaplan DE, Bosch J, Ripoll C, et al. AASLD practice guidance on risk stratification and management of portal hypertension and varices in cirrhosis. Hepatology 2023.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tripathi D, Stanley AJ, Hayes PC, et al. U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients. Gut 2015; 64:1680.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de Franchis R, Bosch J, Garcia-Tsao G, et al. Baveno VII - Renewing consensus in portal hypertension. J Hepatol 2022; 76:959.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Northup PG, Garcia-Pagan JC, Garcia-Tsao G, et al. Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases. Hepatology 2021; 73:366.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lo GH, Lai KH, Shen MT, Chang CF. A comparison of the incidence of transient bacteremia and infectious sequelae after sclerotherapy and rubber band ligation of bleeding esophageal varices. Gastrointest Endosc 1994; 40:675.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Cárdenas A. Management of acute variceal bleeding: emphasis on endoscopic therapy. Clin Liver Dis 2010; 14:251.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Poza Cordon J, Froilan Torres C, Burgos García A, et al. Endoscopic management of esophageal varices. World J Gastrointest Endosc 2012; 4:312.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Saeed ZA. The Saeed Six-Shooter: a prospective study of a new endoscopic multiple rubber-band ligator for the treatment of varices. Endoscopy 1996; 28:559.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Wong T, Pereira SP, McNair A, Harrison PM. A prospective, randomized comparison of the ease and safety of variceal ligation using a multiband vs. a conventional ligation device. Endoscopy 2000; 32:931.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           McKiernan PJ, Beath SV, Davison SM. A prospective study of endoscopic esophageal variceal ligation using a multiband ligator. J Pediatr Gastroenterol Nutr 2002; 34:207.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           ASGE Technology Committee, Liu J, Petersen BT, et al. Endoscopic banding devices. Gastrointest Endosc 2008; 68:217.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Laine L. Management of actively bleeding esophageal varices. Gastrointest Endosc 1997; 46:83.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ramirez FC, Colon VJ, Landan D, et al. The effects of the number of rubber bands placed at each endoscopic session upon variceal outcomes: a prospective, randomized study. Am J Gastroenterol 2007; 102:1372.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Osman D, Djibré M, Da Silva D, et al. Management by the intensivist of gastrointestinal bleeding in adults and children. Ann Intensive Care 2012; 2:46.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chen CW, Kuo CJ, Lee CW, et al. Albumin-Bilirubin Grade as a Novel Predictor of the Development and Short-Term Survival of Post-Banding Ulcer Bleeding Following Endoscopic Variceal Ligation in Cirrhotic Patients. Medicina (Kaunas) 2022; 58.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dueñas E, Cachero A, Amador A, et al. Ulcer bleeding after band ligation of esophageal varices: Risk factors and prognosis. Dig Liver Dis 2020; 52:79.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Young MF, Sanowski RA, Rasche R. Comparison and characterization of ulcerations induced by endoscopic ligation of esophageal varices versus endoscopic sclerotherapy. Gastrointest Endosc 1993; 39:119.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nijhawan S, Rai RR, Nepalia S, et al. Natural history of postligation ulcers. Am J Gastroenterol 1994; 89:2281.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hou MC, Lin HC, Chen CH, et al. Changes in portal hypertensive gastropathy after endoscopic variceal sclerotherapy or ligation: an endoscopic observation. Gastrointest Endosc 1995; 42:139.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sarin SK, Shahi HM, Jain M, et al. The natural history of portal hypertensive gastropathy: influence of variceal eradication. Am J Gastroenterol 2000; 95:2888.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Panés J, Bordas JM, Piqué JM, et al. Increased gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy. Gastroenterology 1992; 103:1875.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tayama C, Iwao T, Oho K, et al. Effect of large fundal varices on changes in gastric mucosal hemodynamics after endoscopic variceal ligation. Endoscopy 1998; 30:25.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           de la Peña J, Rivero M, Sanchez E, et al. Variceal ligation compared with endoscopic sclerotherapy for variceal hemorrhage: prospective randomized trial. Gastrointest Endosc 1999; 49:417.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lo GH, Liang HL, Lai KH, et al. The impact of endoscopic variceal ligation on the pressure of the portal venous system. J Hepatol 1996; 24:74.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Yoshikawa I, Murata I, Nakano S, Otsuki M. Effects of endoscopic variceal ligation on portal hypertensive gastropathy and gastric mucosal blood flow. Am J Gastroenterol 1998; 93:71.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Pereira-Lima JC, Zanette M, Lopes CV, de Mattos AA. The influence of endoscopic variceal ligation on the portal pressure gradient in cirrhotics. Hepatogastroenterology 2003; 50:102.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Stiegmann GV, Goff JS, Michaletz-Onody PA, et al. Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices. N Engl J Med 1992; 326:1527.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Goff JS, Reveille RM, Stiegmann GV. Three years experience with endoscopic variceal ligation for treatment of bleeding varices. Endoscopy 1992; 24:401.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schmitz RJ, Sharma P, Badr AS, et al. Incidence and management of esophageal stricture formation, ulcer bleeding, perforation, and massive hematoma formation from sclerotherapy versus band ligation. Am J Gastroenterol 2001; 96:437.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schoonbroodt D, Zipf A, Jung M. Local necrosis and fatal perforation of oesophagus after endoscopic ligation. Lancet 1994; 344:1365.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nikoloff MA, Riley TR 3rd, Schreibman IR. Complete esophageal obstruction following endoscopic variceal ligation. Gastroenterol Hepatol (N Y) 2011; 7:557.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hou MC, Yen TC, Lin HC, et al. Sequential changes of esophageal motility after endoscopic injection sclerotherapy or variceal ligation for esophageal variceal bleeding: a scintigraphic study. Am J Gastroenterol 1997; 92:1875.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Debette S, Gauvrit JY, Desseaux G, et al. Paraplegia after ligation of esophageal varices. Neurology 2003; 60:879.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Iida T, Shijo H, Yokoyama M, et al. Effects of endoscopic variceal ligation on oxygen transport and the arterial lactate levels in patients with cirrhosis. Am J Gastroenterol 1998; 93:1340.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 1264 Version 25.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3487484" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : A new endoscopic elastic band ligating device.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2792677" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Endoscopic variceal ligation: an alternative to sclerotherapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/3259195" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : Endoscopic esophageal varix ligation: preliminary clinical experience.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37870298" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : AASLD practice guidance on risk stratification and management of portal hypertension and varices in cirrhosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25887380" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/35120736" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Baveno VII - Renewing consensus in portal hypertension.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33219529" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Vascular Liver Disorders, Portal Vein Thrombosis, and Procedural Bleeding in Patients With Liver Disease: 2020 Practice Guidance by the American Association for the Study of Liver Diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7859963" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : A comparison of the incidence of transient bacteremia and infectious sequelae after sclerotherapy and rubber band ligation of bleeding esophageal varices.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20682233" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Management of acute variceal bleeding: emphasis on endoscopic therapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22816012" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Endoscopic management of esophageal varices.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8911804" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : The Saeed Six-Shooter: a prospective study of a new endoscopic multiple rubber-band ligator for the treatment of varices.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11147940" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : A prospective, randomized comparison of the ease and safety of variceal ligation using a multiband vs. a conventional ligation device.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11840041" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : A prospective study of endoscopic esophageal variceal ligation using a multiband ligator.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18656592" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Endoscopic banding devices.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9260714" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Management of actively bleeding esophageal varices.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17437506" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : The effects of the number of rubber bands placed at each endoscopic session upon variceal outcomes: a prospective, randomized study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23140348" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Management by the intensivist of gastrointestinal bleeding in adults and children.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36557038" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Albumin-Bilirubin Grade as a Novel Predictor of the Development and Short-Term Survival of Post-Banding Ulcer Bleeding Following Endoscopic Variceal Ligation in Cirrhotic Patients.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31395524" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Ulcer bleeding after band ligation of esophageal varices: Risk factors and prognosis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8495829" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Comparison and characterization of ulcerations induced by endoscopic ligation of esophageal varices versus endoscopic sclerotherapy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7977270" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : Natural history of postligation ulcers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7590049" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Changes in portal hypertensive gastropathy after endoscopic variceal sclerotherapy or ligation: an endoscopic observation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11051364" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : The natural history of portal hypertensive gastropathy: influence of variceal eradication.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1451980" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Increased gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9548040" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Effect of large fundal varices on changes in gastric mucosal hemodynamics after endoscopic variceal ligation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10202052" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Variceal ligation compared with endoscopic sclerotherapy for variceal hemorrhage: prospective randomized trial.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/8834028" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : The impact of endoscopic variceal ligation on the pressure of the portal venous system.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9448178" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Effects of endoscopic variceal ligation on portal hypertensive gastropathy and gastric mucosal blood flow.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12630002" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : The influence of endoscopic variceal ligation on the portal pressure gradient in cirrhotics.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1579136" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : Endoscopic sclerotherapy as compared with endoscopic ligation for bleeding esophageal varices.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/1505488" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Three years experience with endoscopic variceal ligation for treatment of bleeding varices.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11232687" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Incidence and management of esophageal stricture formation, ulcer bleeding, perforation, and massive hematoma formation from sclerotherapy versus band ligation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/7968049" id="rid32" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          33 : Local necrosis and fatal perforation of oesophagus after endoscopic ligation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/22298995" id="rid33" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          34 : Complete esophageal obstruction following endoscopic variceal ligation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9382056" id="rid34" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          35 : Sequential changes of esophageal motility after endoscopic injection sclerotherapy or variceal ligation for esophageal variceal bleeding: a scintigraphic study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12629254" id="rid35" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          36 : Paraplegia after ligation of esophageal varices.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9707062" id="rid36" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          37 : Effects of endoscopic variceal ligation on oxygen transport and the arterial lactate levels in patients with cirrhosis.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
